The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.

Abstract

BACKGROUND Adjuvant systemic therapy prolongs disease-free and overall survival in both pre- and postmenopausal patients. Available data shown benefit from multi-agent chemotherapy, prolonged tamoxifen treatment, and ovarian ablation, and that the combination of chemo- and endocrine therapy might be advantageous. In 1978 the International (Ludwig) Breast… (More)

Topics

Cite this paper

@article{CastiglioneGertsch1994TheI, title={The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.}, author={Monica Castiglione-Gertsch and Christina Johnsen and Aaron Goldhirsch and Robert Gelber and C. M. Rudenstam and J. Collins and Jurii Lindtner and Andrew Hacking and Hern{\'a}n Cort{\'e}s-Fun{\'e}s and J. F. Forbes}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year={1994}, volume={5 8}, pages={717-24} }